• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与原发性纤毛运动障碍相关研究的重点与障碍

Priorities and barriers for research related to primary ciliary dyskinesia.

作者信息

Goutaki Myrofora, Lam Yin Ting, Rubbo Bruna, Chalmers James D, Kouis Panayiotis, Marsh Gemma, Papon Jean-François, Raidt Johanna, Robinson Phil, Behan Laura, Lucas Jane S

机构信息

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.

出版信息

ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00026-2024. eCollection 2024 Sep.

DOI:10.1183/23120541.00026-2024
PMID:39351388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11440378/
Abstract

BACKGROUND

Despite advances in primary ciliary dyskinesia (PCD) research, many questions remain; diagnosis is complex and no disease-specific therapies exist. Using a mixed-methods approach, we aimed to identify priorities for clinical and epidemiological research and explore barriers to research.

METHODS

To obtain rich, relevant, diverse data, we performed in-depth semi-structured interviews with PCD specialists selected using purposive sampling. We transcribed, coded and analysed interview data using thematic analysis. Based on interview themes that we identified, we developed an anonymous survey and circulated it widely through the BEAT-PCD network.

RESULTS

We interviewed 28 participants from 15 countries across different disciplines and expertise levels. The main themes identified as priorities for PCD research were improving diagnosis; understanding prevalence and disease course; phenotypic variability; disease monitoring; treatment strategies; clinical trial end-points; and poorly researched areas. In total, 136 participants (49% paediatric pulmonologists) from 36 countries completed the survey. Most commonly reported barriers for research were low awareness about PCD and difficulties securing funding - in more than one-third of cases, participants reported undertaking predominantly unfunded research. Research questions ranked highest included priorities related to further improving diagnosis, treating PCD, managing upper and lower airway problems, and studying clinical variability and disease prognosis.

CONCLUSION

We need to overcome barriers of limited funding and low awareness and promote collaborations between centres, disciplines, experts and patients to address identified PCD priorities effectively. Our results contribute to the ongoing efforts of guiding the use of existing limited research resources and setting up a roadmap for future research activities.

摘要

背景

尽管原发性纤毛运动障碍(PCD)研究取得了进展,但仍存在许多问题;诊断复杂,且不存在针对该疾病的特异性疗法。我们采用混合方法,旨在确定临床和流行病学研究的重点,并探讨研究障碍。

方法

为获取丰富、相关且多样的数据,我们对采用目的抽样法选取的PCD专家进行了深入的半结构化访谈。我们使用主题分析法对访谈数据进行转录、编码和分析。基于我们确定的访谈主题,我们编制了一份匿名调查问卷,并通过“战胜PCD”网络广泛分发。

结果

我们采访了来自15个国家、不同学科和专业水平的28名参与者。确定为PCD研究重点的主要主题包括改善诊断;了解患病率和疾病进程;表型变异性;疾病监测;治疗策略;临床试验终点;以及研究较少的领域。来自36个国家的136名参与者(49%为儿科肺病专家)完成了调查。最常报告的研究障碍是对PCD的认识不足以及获得资金困难——在超过三分之一的案例中,参与者报告主要开展无资金支持的研究。排名最高的研究问题包括与进一步改善诊断、治疗PCD、管理上呼吸道和下呼吸道问题以及研究临床变异性和疾病预后相关的重点。

结论

我们需要克服资金有限和认识不足的障碍,促进各中心、学科、专家和患者之间的合作,以有效解决已确定的PCD重点问题。我们的研究结果有助于持续努力指导现有有限研究资源的使用,并为未来的研究活动制定路线图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baf/11440378/32439f30551e/00026-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baf/11440378/dab62bf2550e/00026-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baf/11440378/32439f30551e/00026-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baf/11440378/dab62bf2550e/00026-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7baf/11440378/32439f30551e/00026-2024.02.jpg

相似文献

1
Priorities and barriers for research related to primary ciliary dyskinesia.与原发性纤毛运动障碍相关研究的重点与障碍
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00026-2024. eCollection 2024 Sep.
2
The Swiss Primary Ciliary Dyskinesia registry: objectives, methods and first results.瑞士原发性纤毛运动障碍登记处:目标、方法及初步结果。
Swiss Med Wkly. 2019 Jan 13;149. doi: 10.57187/smw.2019.20004. eCollection 2019 Jan 1.
3
Infertility and pregnancy outcomes among adults with primary ciliary dyskinesia.原发性纤毛运动障碍成年患者的不孕不育与妊娠结局
Hum Reprod Open. 2024 Jun 18;2024(3):hoae039. doi: 10.1093/hropen/hoae039. eCollection 2024.
4
Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment Strategies.原发性纤毛运动障碍:临床方面、遗传学、诊断及未来治疗策略的最新进展
Front Pediatr. 2017 Jun 9;5:135. doi: 10.3389/fped.2017.00135. eCollection 2017.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
[Primary ciliary dyskinesia (Pcd) in Austria].[奥地利的原发性纤毛运动障碍(Pcd)]
Wien Klin Wochenschr. 2009;121(19-20):616-22. doi: 10.1007/s00508-009-1197-4.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Study protocol: the ear-nose-throat (ENT) prospective international cohort of patients with primary ciliary dyskinesia (EPIC-PCD).研究方案:耳-鼻-喉(ENT)原发性纤毛运动障碍(EPIC-PCD)患者国际前瞻性队列研究。
BMJ Open. 2021 Oct 11;11(10):e051433. doi: 10.1136/bmjopen-2021-051433.
9
Proceedings of the 4 BEAT-PCD Conference and 5 PCD Training School.第四届BEAT-PCD会议暨第五届PCD培训学校会议论文集
BMC Proc. 2020 Jun 19;14(Suppl 8):7. doi: 10.1186/s12919-020-00191-3. eCollection 2020.
10
Living with primary ciliary dyskinesia: a prospective qualitative study of knowledge sharing, symptom concealment, embarrassment, mistrust, and stigma.原发性纤毛运动障碍患者的生活:一项关于知识共享、症状隐瞒、尴尬、不信任和污名化的前瞻性定性研究。
BMC Pulm Med. 2006 Oct 13;6:25. doi: 10.1186/1471-2466-6-25.

本文引用的文献

1
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia.一项BEAT-PCD共识声明:原发性纤毛运动障碍肺部疾病干预的核心结局集
ERJ Open Res. 2024 Jan 8;10(1). doi: 10.1183/23120541.00115-2023. eCollection 2024 Jan.
2
The European reference network on rare lung diseases (ERN-LUNG) ambition to offer better lung health for all.欧洲罕见肺病参考网络(ERN-LUNG)旨在为所有人提供更好的肺部健康。
Presse Med. 2023 Sep;52(3):104172. doi: 10.1016/j.lpm.2023.104172. Epub 2023 Sep 10.
3
Diagnostic testing in people with primary ciliary dyskinesia: An international participatory study.
原发性纤毛运动障碍患者的诊断检测:一项国际参与性研究。
PLOS Glob Public Health. 2023 Sep 11;3(9):e0001522. doi: 10.1371/journal.pgph.0001522. eCollection 2023.
4
Restoring Ciliary Function: Gene Therapeutics for Primary Ciliary Dyskinesia.恢复纤毛功能:原发性纤毛运动障碍的基因治疗。
Hum Gene Ther. 2023 Sep;34(17-18):821-835. doi: 10.1089/hum.2023.102.
5
The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN.原发性纤毛运动障碍疾病特异性临床试验网络:PCD-CTN
ERJ Open Res. 2022 Aug 15;8(3). doi: 10.1183/23120541.00139-2022. eCollection 2022 Jul.
6
The ERN-LUNG Population Registry: Aims, Software-Implementation and First Results.ERN-LUNG 人群登记研究:目的、软件实现和初步结果。
Stud Health Technol Inform. 2022 Jun 29;295:55-58. doi: 10.3233/SHTI220659.
7
Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis.基因组测序揭示了支气管扩张症中原发性纤毛运动障碍的漏诊。
Eur Respir J. 2022 Nov 17;60(5). doi: 10.1183/13993003.00176-2022. Print 2022 Nov.
8
A practical guide to reflexivity in qualitative research: AMEE Guide No. 149.质性研究中反思性的实用指南:AMEE指南第149号
Med Teach. 2022 Apr 7:1-11. doi: 10.1080/0142159X.2022.2057287.
9
Diagnosis of Primary Ciliary Dyskinesia.原发性纤毛运动障碍的诊断。
Clin Chest Med. 2022 Mar;43(1):127-140. doi: 10.1016/j.ccm.2021.11.008.
10
The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis.原发性纤毛运动障碍基因变异的全球流行率和种族异质性:遗传数据库分析。
Lancet Respir Med. 2022 May;10(5):459-468. doi: 10.1016/S2213-2600(21)00453-7. Epub 2022 Jan 17.